Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas

Leukemia and Lymphoma

Volumn 43, Issue 9, 2002, Pages 1769-1775

  Lee, Hoon K ^a   Wilder, Richard B ^a   Jones, Dan ^a   Ha, Chul S ^a   Pro, Barbara ^a   Rodriguez, Maria A ^a   Romaguera, Jorge E ^a   Cabanillas, Fernando ^a   Rodriguez, Jose ^b   Cox, James D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Chemotherapy; Prognosis; Radiotherapy; T cell lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; METHYLPREDNISOLONE; PLATINUM; PREDNISONE; VINCRISTINE;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CENTER; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EAR CANCER; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL TIME; T CELL LYMPHOMA; TREATMENT OUTCOME; UNITED STATES; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 6444245388     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000006277     Document Type: Article

References (38)

1. "The prognostic significance of the immunotype in diffuse large-cell lymphoma: A comparative study of the T-cell and B-cell phenotype"
2. "Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: A prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives)"
3. "Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma"
4. "Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma"
5. "Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)"
6. "Direct comparisons ofperipheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades-should peripheral T-cell lymphoma be considered separately?"
7. "Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: The Stanford experience"
8. "Aggressive non-Hodgkin's lymphoma: T-cell versus B-cell"
9. "World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997"
10. "Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the REAL. Classification"
11. "A clinical Evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma"
12. "Changing trends in the incidence of non-Hodgkin's lymphoma in Europe Biomed Study Group"
13. "CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin's lymphomas: Update of the Southwest Oncology Group (SWOG) randomized trial"
14. "Final report of E1484: CHOP v CHOP + radiotherapy (RT) for limited stage diffuse aggressive lymphoma"
15. "Superiority of the ACVBP regimen over a combined treatment with three cycles of CHOP followed by involved field radiotherapy in patients (pts) with low risk localized aggressive non-Hodgkin's lymphoma: Results of the LNH93-1 study"
16. "A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the tumor score"
17. "A predictive model for aggressive non-Hodgkin's lymphoma."
18. "Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine and prednisone with or without radiotherapy for aggressive lymphoma"
19. "Angiocentric nasal T/natural killer cell lymphoma: A single centre study of prognostic factors in 108 patients"
20. "Beta-2 microglobulin: A prognostic factor in diffuse aggressive non-Hodgkin's lymphomas"
21. "Report of the committee on Hodgkin's disease staging classification"
22. "Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas"
23. "Nonparametric estimation from incomplete observations"
24. "Evaluation of survival data and two rank order statistics arising in its consideration"
25. "ALK + lymphoma: Clinico-pathological findings and outcome"
26. "Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma"
27. "Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma"
28. "Peripheral T-cell lymphoma"
29. "Non-Hodgkin's malignant lymphoma of the sinonasal tract-treatment outcome for 53 patients according to REAL classification"
30. "Impact of high-dose chemotherapy on peripheral T-cell lymphomas"
31. "CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?"
32. "CD56 + NK lymphomas: Clinicopathological features and prognosis"
33. "Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment"
34. "Nasal-type T/NK lymphomas: A clinicopathologic study of 13 cases"
35. "Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma"
36. "CD30(+) anaplastic large cell lymphoma: A review of its histopathologic, genetic, and clinical features"
37. "Clinical stage IE primary lymphoma of the nasal cavity: Radiation therapy and chemotherapy"
38. "Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology"